Select your country or region to view content specific to your country.
Seeplex® RV7 Detection Simultaneously detecting major respiratory viruses
Jun 02, 2009| Seeplex® RV7 Detection
Simultaneous detection of 12 major respiratory viruses Obtained Medical Device License By Health Canada : Seeplex® RV12 ACE Detection
Nov 04, 2008| Seeplex® RV12 ACE Detection
Seeplex® RV5 ACE Screening Rapid screening of most prevalent respiratory viruses Seeplex® RV5 ACE Screening has been given a Medical Device License by Health Canada. The licenses will enhance the opportunity in the Canadian market.NOT AVAILABLE IN US Seeplex® RV 12 ACE Detection Simultaneously detection 12 major respiratory viruses Seeplex® RV 12 ACE Detection has been given a Medical Device License by Health Canada. The licenses will enhance the opportunity in the Canadian market.
Nov 03, 2008| Seeplex® RV5 ACE Screening
Simultaneous detection of 12 major respiratory viruses Seegene's Seeplex® RV12 ACE Detection, RV5 ACE Screening have been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jun 30, 2008| Seeplex® RV12 ACE Detection
Accurately detecting 6 pneumonial bacteria at once Seegene's Seeplex® PneumoBacter ACE Detection have been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jun 30, 2008| Seeplex® PneumoBacter ACE Detection
Seeplex® RV12 ACE DetectionSimultaneously detecting 12 major respiratory virusesSeeplex® RV 12 ACE Detection is designed to detect major respiratory viruses. The conventional methods (culture and IFA, etc.) to detect respiratory viruses take several days or do not have enough sensitivity. Therefore, many of the recently developed diagnostic methods employ PCR methods. Among them, Seegene's Respiratory Virus Detection is outstanding in terms of sensitivity and specificity by applying DPO™ technology and detects multiple respiratory viruses by Multiplex RT-PCR.
Jun 03, 2008| Seeplex® RV12 ACE Detection
Seeplex® RV/PB18 ASE DetectionDetecting Major Respiratory PathogensSeeplex® RV/PB18 ASE Detection is designed to detect simultaneously 13 respiratory viruses and 5 pneumonia bacteria. Existing diagnostic methods have tested for some viruses and some bacteria. However, it is difficult to accurately diagnose co-infection of viruses and bacteria because until now there has been no method to detect two types using one test, and thus the proper prescription cannot be made at the appropriate time. Seegene's products make it possible to prescribe quickly in the early stage of symptoms with just one test by determining whether a respiratory infection has been caused by viruses or bacteria or both. If the influenza A or influenza B virus is detected using Seegene products, Oseltamivir or Zanamavir can be prescribed. If the respiratory syncytial virus is detected using Seegene products, Ribavirin can be prescribed. This product will help with the development of specific antiviral preparations and antibiotics in the long term, and ultimately make customized prescriptions possible. Capillary-based auto sequencers including ABI 3130/3100 are applicable for Seeplex® RV/PB18 ASE Detection.
Jun 01, 2008| Seeplex® RV/PB18 ASE Detection
Seeplex® RV5 ACE Screening Rapid screening of the most prevalent respiratory virusesSeeplex® RV5 ACE Screening is designed to screen the most prevalent respiratory viruses. The conventional methods (culture and IFA, etc.) to detect respiratory viruses take several days or do not have enough sensitivity. Therefore, many of the recently developed diagnostic methods employ PCR methods. Among them, Seegene's Respiratory Virus Detection is outstanding in terms of sensitivity and specificity by applying DPO™ technology and detects multiple respiratory viruses by Multiplex RT-PCR
Mar 01, 2008| Seeplex® RV5 ACE Screening